The bipartisan panel has asked 4 drug makers, including Turing Pharmaceuticals, to submit documents to the US Senate's Special Committee on Aging.
Four companies—Valeant Pharmaceuticals, Turing Pharmaceuticals, Retrophin Inc, and Rodelis Therapeutics—have been reprimanded by the US Senate's Special Committee on Aging. This is a result of the unreasonable drug price hikes of generic drugs that had been acquired by these companies. Additionally, Democrats want to vote on issuing a subpeona to both Valeant and Turing Pharmaceuticals.
"We need to get to the bottom of why we're seeing huge spikes in drug prices that seemingly have no relationship to research and development costs," said Senator Claire McCaskill, D-Missouri, in a statement. She added that some of the increases resemble "little more than price gouging."
Read more on Reuters.
Promoting Health Equity and Resiliency in Trauma-Affected Communities
January 31st 2023On this episode of Managed Care Cast, we speak with Reverend Paul Abernathy, CEO of the Neighborhood Resilience Project and board member of UPMC for You, who discusses his experiences in promoting health and resiliency in trauma-affected communities, as well as challenges related to access and accessibility of care and medical mistrust.
Listen
Interventions for Children With ADHD Might Improve Sleep Outcomes
February 1st 2023Behavioral and combined behavioral and pharmacological interventions were investigated for their potential to help improve sleep outcomes in children with attention-deficit/hyperactivity disorder (ADHD).
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Study Suggests MRI Is the Best Breast Cancer Screening Modality for Dense Breasts
February 1st 2023A review and meta-analysis published in the journal Radiology found MRI to be the most effective supplemental breast cancer screening method for women with dense breasts and negative mammogram results.
Read More
2 Clarke Drive
Cranbury, NJ 08512